Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants - 2Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- 3Police break up illegal chicken slaughter in Germany
- 4Polar bears are rewiring their own genetics to survive a warming climate
- 5Ancient Egyptian pharaoh's boat is being reassembled in public at the Grand Egyptian Museum
- Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints.
- Ukraine's new defense minister just outlined how dire its troop shortage has become
- The Development of Shipping: Controlling Towards a More Associated Future
- Can scientists detect life without knowing what it looks like? Research using machine learning offers a new way
- Building an Individual Brand: Illustrations from Powerhouses
- Instructions to Comprehend and Use Open Record Extra Offers
- Palestinian infant freezes to death in Gaza as Israel keeps blocking aid
- The most effective method to Connect Successfully with Teachers in a Web based Setting
